Merck New’s digital transformation strategy involves fundamental changes across its core operations. Merck New implements sophisticated AI models into drug discovery workflows to accelerate research and development. This transformation leverages advanced analytics platforms and cloud infrastructure to manage vast datasets and scientific processes. Merck New's approach also includes modernizing manufacturing processes through smart factory initiatives and digitalization of supply chain operations.
This comprehensive transformation creates critical dependencies on robust data pipelines and integrated enterprise systems. It introduces risks such as data inconsistencies between diverse platforms and process breakdowns during complex workflow automation. This page analyzes Merck New’s specific digital initiatives, associated challenges, and opportunities for solution providers.
Merck New Snapshot
Headquarters: Rahway, United States
Number of employees: Approximately 75,000 employees
Public or private: Public
Business model: B2B
Website: http://www.merck.com
Merck New ICP and Buying Roles
Who Merck New sells to
-
Companies with complex research, manufacturing, and distribution requirements.
-
Organizations navigating stringent regulatory compliance and global supply chain logistics.
Who drives buying decisions
-
Chief Information Officer (CIO) → Oversees enterprise-wide IT strategy and cloud infrastructure adoption.
-
Chief Digital Officer (CDO) → Directs digital transformation across R&D, manufacturing, and commercial functions.
-
Head of Research & Development IT → Manages technology supporting drug discovery, clinical trials, and data analytics platforms.
-
VP, Manufacturing Operations → Leads smart factory initiatives, production automation, and operational technology integration.
-
Head of Global Supply Chain → Drives digitalization of logistics, inventory management, and supplier networks.
-
Chief Medical Officer (CMO) → Guides AI applications in clinical development and patient engagement strategies.
Key Digital Transformation Initiatives at Merck New (At a Glance)
-
Integrating generative AI into drug discovery workflows.
-
Deploying AI agents for clinical document creation and analysis.
-
Implementing smart manufacturing platforms across global production sites.
-
Migrating core SAP workloads and clinical data platforms to AWS cloud.
-
Establishing an agentic AI platform for commercial content and HCP engagement.
-
Adopting digital twin technology for R&D, manufacturing, and supply chain.
-
Embedding AI into supply chain planning and logistics systems.
Where Merck New’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| AI Governance & Validation | Integrating generative AI into drug discovery: AI-generated molecule predictions do not align with known chemical properties. | Head of R&D IT, Chief Medical Officer | Validate AI model outputs against established scientific databases. |
| Deploying AI agents for clinical document creation: automated drafts contain inaccurate data interpretations from source documents. | VP, Clinical Operations, Head of R&D IT | Detect discrepancies between AI-generated text and original clinical trial data. | |
| Establishing agentic AI for commercial content: AI-produced marketing materials contain off-brand messaging or medical inaccuracies. | Chief Marketing Officer, Chief Digital Officer | Enforce brand guidelines and medical accuracy during AI content generation. | |
| Industrial IoT & OT Security | Implementing smart manufacturing platforms: real-time sensor data from production lines does not propagate to central analytics systems. | VP, Manufacturing Operations, Head of OT | Standardize data ingestion from diverse IoT sensors into a unified platform. |
| Adopting digital twin technology for manufacturing: virtual model data does not reflect physical asset performance due to sensor calibration. | VP, Manufacturing Operations, Head of OT | Calibrate industrial sensors to synchronize digital twin accuracy. | |
| Cloud Migration & Data Platforms | Migrating core SAP workloads to AWS cloud: transaction data fails to synchronize between legacy on-premise ERP and cloud SAP instances. | Chief Information Officer, Head of Enterprise Architecture | Route data changes consistently between hybrid cloud environments. |
| Modernizing clinical data platforms on AWS: patient record data from disparate systems creates duplicate entries in the central repository. | Head of R&D IT, VP, Data Management | Detect and deduplicate patient records during data ingestion. | |
| Supply Chain Orchestration | Embedding AI into supply chain planning: predictive models generate inaccurate demand forecasts due to incomplete market data. | Head of Global Supply Chain, VP, Logistics | Validate external market data before feeding into AI forecasting models. |
| Digitalizing supply chain operations: tracking data from logistics partners does not integrate with internal inventory management systems. | Head of Global Supply Chain, VP, Procurement | Standardize inbound logistics data for real-time inventory updates. |
Identify when companies like Merck New are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Merck New’s digital transformation unique
Merck New's digital transformation prioritizes a deep integration of AI across scientific R&D and operational functions. The company emphasizes agentic AI to automate complex tasks within drug discovery and clinical documentation workflows. This strategy creates a heavy reliance on robust data governance and interoperability between specialized platforms. Merck New's investment in smart manufacturing and digital twins distinguishes its approach by applying advanced digital models to physical production environments.
Merck New’s Digital Transformation: Operational Breakdown
DT Initiative 1: Integrating generative AI into drug discovery workflows
What the company is doing
Merck New embeds generative AI within its research labs to design novel molecules and predict their properties. This initiative includes the AIDDISSON software platform which simulates chemical reactions and evaluates synthesis routes. The company partners with external AI platforms to expand its compound screening capabilities.
Who owns this
- Head of Research & Development IT
- Chief Science & Technology Officer
- VP, Drug Discovery
- Head of Data Science
Where It Fails
- AI-generated molecular structures do not meet solubility requirements.
- Predicted synthesis pathways by AIDDISSON software introduce unfeasible reaction steps.
- External AI platforms generate compound libraries with low therapeutic potential.
- Data pipelines from experimental results fail to update AI models for iterative learning.
Talk track
Noticed Merck New integrates generative AI into drug discovery workflows. Been looking at how some pharmaceutical teams validate AI-generated molecule predictions against known chemical properties, can share what’s working if useful.
DT Initiative 2: Implementing smart manufacturing platforms across global production sites
What the company is doing
Merck New deploys intelligent platforms like Siemens Xcelerator for modular production and real-time process control in factories. This transformation integrates IoT sensors and connected equipment to gather operational data from manufacturing lines. The company transitions from batch to continuous manufacturing processes supported by advanced analytics.
Who owns this
- VP, Manufacturing Operations
- Head of Operational Technology (OT)
- Global Head of Smart Manufacturing
- VP, Engineering
Where It Fails
- IoT sensor data from production machines contains erroneous readings before ingestion into the data lake.
- Modular production units fail to integrate with existing legacy control systems during reconfigurations.
- Predictive maintenance alerts from smart factory systems trigger for non-critical equipment conditions.
- Continuous manufacturing parameters deviate without automated system adjustments.
Talk track
Saw Merck New deploys smart manufacturing platforms across global sites. Been looking at how some biopharma teams standardize data ingestion from diverse IoT sensors into a unified platform, happy to share what we’re seeing.
DT Initiative 3: Migrating core SAP workloads and clinical data platforms to AWS cloud
What the company is doing
Merck New moves its critical SAP enterprise resource planning (ERP) systems and clinical trial data repositories to Amazon Web Services (AWS). This initiative establishes a comprehensive cloud-based data platform to handle analytics and transactional needs across numerous clinical studies. It involves migrating machine learning and data warehouses to a scalable cloud environment.
Who owns this
- Chief Information Officer (CIO)
- Head of Enterprise Architecture
- VP, Cloud & Infrastructure Technology
- Head of Data Management
Where It Fails
- Transaction data from migrated SAP ERP modules does not reconcile with on-premise financial reporting systems.
- Clinical trial data streams fail to transfer securely to AWS S3 buckets due to network misconfigurations.
- Data warehouse queries on AWS generate inconsistent results compared to previous on-premise reports.
- Access controls for sensitive patient data in the cloud-based clinical platform do not meet regulatory compliance.
Talk track
Looks like Merck New migrates core SAP workloads and clinical data platforms to AWS cloud. Been seeing teams route data changes consistently between hybrid cloud environments, can share what’s working if useful.
DT Initiative 4: Establishing an agentic AI platform for commercial content and HCP engagement
What the company is doing
Merck New implements an agentic AI system with Google Cloud to personalize content creation and distribution for Healthcare Professionals (HCPs). This initiative leverages AI to generate market research insights and streamline regulatory submissions. The platform aims to deliver tailored information to doctors and healthcare systems rapidly.
Who owns this
- Chief Digital Officer
- Chief Marketing Officer
- VP, Commercial Operations
- Head of Regulatory Affairs
Where It Fails
- AI-generated HCP engagement content contains medical inaccuracies before review.
- Market research insights from the agentic AI platform omit critical regional nuances.
- Regulatory submission documents compiled by AI agents require extensive manual reformatting.
- Personalized information delivery through the digital backbone fails to reach target HCP segments.
Talk track
Noticed Merck New establishes an agentic AI platform for commercial content and HCP engagement. Been looking at how some pharma teams enforce brand guidelines and medical accuracy during AI content generation, happy to share what we’re seeing.
DT Initiative 5: Embedding AI into supply chain planning and logistics systems
What the company is doing
Merck New integrates AI to forecast demand, predict disruptions, and automate corrective actions across its complex supply chain network. This initiative involves software that aggregates data from multiple ERP systems for comprehensive visibility. The company uses AI to optimize inventory levels and reroute orders in response to bottlenecks.
Who owns this
- Head of Global Supply Chain
- Chief Information Officer (CIO)
- VP, Logistics
- VP, Procurement
Where It Fails
- AI-driven demand forecasts deviate significantly from actual product uptake, causing stockouts.
- Supply chain visibility platforms receive incomplete data from third-party logistics providers.
- Automated re-routing decisions by AI systems conflict with established distribution agreements.
- Inventory optimization algorithms generate stock levels that increase carrying costs.
Talk track
Saw Merck New embeds AI into supply chain planning and logistics systems. Been looking at how some global companies validate external market data before feeding into AI forecasting models, can share what’s working if useful.
Who Should Target Merck New Right Now
This account is relevant for:
- AI model governance and explainability platforms
- Industrial control system cybersecurity solutions
- Cloud data migration and integration specialists
- Generative AI content validation tools
- Predictive analytics platforms for supply chain
- Digital twin simulation and synchronization software
Not a fit for:
- Basic project management software without system integrations
- Generic IT staffing agencies without specialized domain expertise
- Standalone marketing automation tools without AI integration
- On-premise legacy infrastructure providers
- Small business accounting software
When Merck New Is Worth Prioritizing
Prioritize if:
- You sell tools that validate AI model outputs against scientific ground truth.
- You sell solutions that prevent industrial control system data corruption.
- You sell platforms that route and reconcile financial data between hybrid cloud ERP environments.
- You sell systems that enforce brand and medical compliance for AI-generated content.
- You sell analytics solutions that validate external market data for supply chain forecasting.
- You sell software that synchronizes digital twin models with real-world asset performance.
Deprioritize if:
- Your solution does not address any of the breakdowns above.
- Your product is limited to basic functionality without enterprise-grade integration capabilities.
- Your offering is not built for highly regulated or multi-system environments.
Who Can Sell to Merck New Right Now
AI Model Governance Platforms
Vianai Systems - This company provides a responsible AI platform that helps enterprises build, deploy, and monitor AI systems with trust and transparency.
Why they are relevant: AI-generated molecule predictions do not align with known chemical properties. Vianai Systems can establish guardrails and validate AI model outputs against established scientific databases, ensuring drug discovery adheres to strict scientific accuracy.
Databricks - This company offers a data intelligence platform that unifies data, analytics, and AI, providing tools for MLOps and model lifecycle management.
Why they are relevant: Automated clinical document drafts contain inaccurate data interpretations from source documents. Databricks can provide robust MLOps capabilities to monitor and refine AI agent performance, ensuring data accuracy during clinical document creation.
Scale AI - This company provides a data platform for AI, offering data annotation, model validation, and human-in-the-loop solutions for complex AI applications.
Why they are relevant: AI-produced marketing materials contain off-brand messaging or medical inaccuracies. Scale AI can provide human-in-the-loop review and validation services for AI-generated commercial content, enforcing brand guidelines and medical accuracy before publication.
Industrial Connectivity & Cybersecurity
Claroty - This company delivers industrial cybersecurity solutions that protect operational technology (OT) and industrial control systems (ICS).
Why they are relevant: Real-time sensor data from production lines does not propagate to central analytics systems. Claroty can secure and monitor OT networks, preventing data loss or tampering during ingestion from diverse IoT sensors into a unified platform.
PTC - This company provides industrial innovation solutions, including IoT platforms, augmented reality, and product lifecycle management software.
Why they are relevant: Modular production units fail to integrate with existing legacy control systems during reconfigurations. PTC solutions can facilitate seamless integration and data exchange between new modular units and legacy OT infrastructure in smart factories.
Kepware (a PTC business) - This company offers industrial connectivity software that links diverse automation devices and applications.
Why they are relevant: IoT sensor data from production machines contains erroneous readings before ingestion into the data lake. Kepware+ can standardize and normalize industrial data at the source, ensuring data quality from IoT sensors before analysis in smart manufacturing systems.
Cloud Data Integration & Management
Talend - This company provides data integration and data governance solutions for cloud, on-premises, and hybrid environments.
Why they are relevant: Transaction data from migrated SAP ERP modules does not reconcile with on-premise financial reporting systems. Talend can route data changes consistently and validate financial data integrity between hybrid cloud ERP instances.
Boomi - This company offers a cloud-native integration platform as a service (iPaaS) for connecting applications, data, and devices.
Why they are relevant: Clinical trial data streams fail to transfer securely to AWS S3 buckets. Boomi can establish secure and reliable data pipelines, ensuring compliant and consistent data transfer for sensitive patient information to cloud storage.
Confluent - This company provides a streaming data platform based on Apache Kafka, enabling real-time data movement and processing.
Why they are relevant: Data warehouse queries on AWS generate inconsistent results compared to previous on-premise reports. Confluent can ensure real-time data consistency across distributed cloud data warehouses, providing a single source of truth for reporting.
Supply Chain Predictive Analytics
o9 Solutions - This company offers an AI-powered integrated business planning platform for demand forecasting, supply chain management, and sales and operations planning.
Why they are relevant: AI-driven demand forecasts deviate significantly from actual product uptake, causing stockouts. o9 Solutions can validate external market data and provide more accurate, real-time demand signals to AI forecasting models, reducing stockouts and overstocking.
Aera Technology - This company provides a "Cognitive Operating System" that uses AI to automate and optimize business processes, including supply chain operations.
Why they are relevant: Automated re-routing decisions by AI systems conflict with established distribution agreements. Aera's platform can detect such conflicts and provide explanations for AI-driven recommendations, allowing for informed manual override or system recalibration.
Kinaxis - This company delivers a concurrent planning platform that connects sales and operations planning, demand planning, and supply planning.
Why they are relevant: Inventory optimization algorithms generate stock levels that increase carrying costs. Kinaxis can simulate different inventory scenarios and provide insights into cost-optimal stock levels, preventing excessive carrying costs.
Final Take
Merck New scales its digital capabilities across R&D, manufacturing, and commercial operations through significant AI and cloud investments. Breakdowns are visible in data validation for AI outputs, system integration within smart factories, and data consistency across cloud migrations. This account presents a strong fit for vendors addressing specific failures in AI governance, industrial connectivity, data integration, and predictive supply chain analytics.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.